These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3377855)

  • 41. Uptake of Lipiodol--cytotoxic conjugates by hepatoblastoma cells.
    Towu E; Al-Mufti R; Spitz L; Marron K; Winslet M
    Br J Surg; 2002 Apr; 89(4):437-41. PubMed ID: 11952584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation.
    Forrest RA; Swift LP; Rephaeli A; Nudelman A; Kimura K; Phillips DR; Cutts SM
    Biochem Pharmacol; 2012 Jun; 83(12):1602-12. PubMed ID: 22414726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA Damage.
    Yu W; Xiang Y; Luo G; Zhao X; Xiao B; Cheng Y; Feng C; Duan C; Xia X; Wong VKW; Dai R
    Cancer Biother Radiopharm; 2018 Aug; 33(6):258-265. PubMed ID: 29957018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM.
    Solary E; Velay I; Chauffert B; Bidan JM; Caillot D; Dumas M; Guy H
    Cancer; 1991 Oct; 68(8):1714-9. PubMed ID: 1913513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doxorubicin cytotoxicity to P388 lymphocytic leukemia as determined by alkaline elution and established assays.
    Russo P; Favoni RE; Zarcone D; Miglietta L; Peluso M; Nicolin A; Bignone F; Parodi S
    Anticancer Res; 1986; 6(6):1297-304. PubMed ID: 3813486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parallel evaluation of doxorubicin-induced genetic damage in human lymphocytes and sperm using the comet assay and spectral karyotyping.
    Baumgartner A; Schmid TE; Cemeli E; Anderson D
    Mutagenesis; 2004 Jul; 19(4):313-8. PubMed ID: 15215331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
    Leverger G; Bancillon A; Schaison G
    Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Approaches to the treatment of acute leukemia and lymphoma in adults.
    Bodey GP; Rodriguez V
    Semin Hematol; 1978 Jul; 15(3):221-61. PubMed ID: 353991
    [No Abstract]   [Full Text] [Related]  

  • 49. Reduction of doxorubicin cytotoxicity by ouabain: correlation with topoisomerase-induced DNA strand breakage in human and hamster cells.
    Lawrence TS
    Cancer Res; 1988 Feb; 48(3):725-30. PubMed ID: 2825982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of childhood acute leukemia.
    Fujimoto T
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1041-51. PubMed ID: 6949424
    [No Abstract]   [Full Text] [Related]  

  • 51. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
    Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
    PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.
    Escherich G; Zimmermann M; Janka-Schaub G;
    Pediatr Blood Cancer; 2013 Feb; 60(2):254-7. PubMed ID: 22948968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
    Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
    Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of dihydrokainate on the capacity of repair of DNA damage and apoptosis induced by doxorubicin.
    Attia SM; Bakheet SA
    Mutagenesis; 2013 May; 28(3):257-61. PubMed ID: 23360835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anthracycline resistance: cytofluorometric study on infantile lymphoblastic leukemia].
    Limonta M; Ubezio P
    Medicina (Firenze); 1989; 9(4):406-8. PubMed ID: 2634227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Membrane alterations by liposomes to enhance clinical efficacy of cytotoxic drugs.
    Rahman A; Dusre L; Forst D; Thierry A; Roh JK; Greenspan A; Treat J
    Prog Clin Biol Res; 1990; 343():281-304. PubMed ID: 2377628
    [No Abstract]   [Full Text] [Related]  

  • 57. Intracellular drug concentration and DNA damage in human childhood leukemic cells exposed to doxorubicin.
    Catapano CV; Ubezio P; Rossi V; Conter V; Jancovich M; D'Incalci M
    Biochem Pharmacol; 1988 May; 37(9):1863-4. PubMed ID: 3377855
    [No Abstract]   [Full Text] [Related]  

  • 58. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
    Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
    Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.
    Bellamy WT; Dorr RT; Dalton WS; Alberts DS
    Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.
    Maniar N; Krishan A; Israel M; Samy TS
    Biochem Pharmacol; 1988 May; 37(9):1763-72. PubMed ID: 2837239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.